ArticleGland surgery2026
Severe intraoperative hypertensive crisis during surgery for phaeochromocytoma/paraganglioma: analysis of pre-operative risk factors.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Phaeochromocytoma and paraganglioma (PPGL) pose an operative challenge, as their manipulation may induce abrupt catecholamine release and severe intraoperative hypertensive crisis (SIHC), which may lead to severe outcomes. While alpha-blockade is standard it may not eliminate this risk and some evidence has challenged its routine use. We seek to understand which pre-operative factors are linked to SIHC. Methods: Retrospective study of a single-centre, single surgeon cohort of patients who underwent PPGL resection. Primary outcome was SIHC, secondary outcomes included overall and major complications, length of stay and vasopressor need at 24 hours from surgery. Results: Forty patients were included in the analysis. Eighty percent of patients were female with a median age of 58 years. The most common presenting symptom was hypertension (60%), while 15% presented with a clinically significant event [syncope, stroke or myocardial infarction (MI)]. SIHC occurred in 10% of patients and was significantly associated to presentation with a clinically significant event (P<0.001), especially MI (P=0.008), and to left-sided tumours (P=0.02). After 24 hours 60% of patients were on vasopressors, most commonly females (P<0.04) and those with high preoperative normetanephrine levels (P=0.02). There were no major complications while overall complications were linked to open surgery (P=0.02). Conclusions: Patients presenting with a clinically significant event and those with left-sided tumours may be more likely to develop SIHC. This knowledge may inform clinical practice, especially anaesthesiological preoperative planning, and guide patient inclusion in upcoming studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.